
Sign up to save your podcasts
Or


Dr Surbhi Sidana from Stanford University in California discusses recent updates on chimeric antigen receptor T-cell therapy for the treatment of multiple myeloma.
CME information and select publications here.
By Dr. Neil Love4.9
5656 ratings
Dr Surbhi Sidana from Stanford University in California discusses recent updates on chimeric antigen receptor T-cell therapy for the treatment of multiple myeloma.
CME information and select publications here.

135 Listeners

318 Listeners

494 Listeners

66 Listeners

31 Listeners

76 Listeners

14 Listeners

17 Listeners

12 Listeners

0 Listeners

115 Listeners

57 Listeners

3,338 Listeners

196 Listeners

44 Listeners

22 Listeners

364 Listeners

189 Listeners

43 Listeners

0 Listeners